Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Body Weight × Mirtazapine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Weight Loss 1 Pancreatic Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Malnutrition 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Body Weight 1

Interventions

Megestrol Acetate 2 Resistance Training 1 Mirtazapine 1 Metformin 1 Exercise 1 Diet Therapy 1 Caseins 1 Caloric Restriction 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00832520 2018-04-10

Phase II Study of Remeron for Cancer Patients Losing More Than 10% of Their Body Weight

New Mexico Cancer Research Alliance

Phase 2 Terminated

13 enrolled 4 charts

Body Weight, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡